Apogee Therapeutics Inc.
(APGE)
undefined
undefined%
At close: undefined
45.00
1.65%
After-hours Dec 13, 2024, 04:41 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 |
Revenue | - | - |
Cost of Revenue | - | - |
Gross Profit | - | - |
Operating Income | -93.00M | -30.73M |
Interest Income | 9.02M | 92.00K |
Pretax Income | -83.98M | -39.78M |
Net Income | -83.98M | -39.78M |
Selling & General & Admin | 24.58M | 2.94M |
Research & Development | 68.42M | 27.79M |
Other Expenses | - | - |
Operating Expenses | 93.00M | 30.73M |
Interest Expense | - | 9.15M |
Selling & Marketing Expenses | - | - |
Cost & Expenses | 93.00M | 30.73M |
Income Tax | - | -33.52K |
Shares Outstanding (Basic) | 25.00M | 50.67M |
Shares Outstanding (Diluted) | 25.01M | 50.67M |
EPS (Basic) | -3.36 | -0.79 |
EPS (Diluted) | -3.36 | -0.79 |
EBITDA | -83.98M | - |
Depreciation & Amortization | 9.02M | 33.52M |